Ludovica Falcioni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ludovica Falcioni has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Albert Saiz
Neuroimmunology Program, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Spain
1 shared publication - Ana Beatriz Serafim
Neuroimmunology Program, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)—CaixaResearch Institute (CRI), University of Barcelona, Spain
1 shared publication - Andrea Salvati
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
1 shared publication - Anna Fetta
IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Neuropsichiatria dell'Età Pediatrica, Italy
1 shared publication - Antonella Gagliano
Department of Human and Pediatric Pathology “Gaetano Barresi”, University of Messina, 98125 Messina, Italy
1 shared publication - Armando Reques
Pathology Department, Vall Hebron University Hospital, CIBERONC, Barcelona, Spain
1 shared publication
Latest Publications
- Open Access
- 1 September 2026
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 13 (5) , e200635
MOGAD-Like Encephalitic Syndromes Without MOG Antibodies in Children
Background and ObjectivesAlthough acute disseminated encephalomyelity (ADEM) can be myelin oligodendrocyte glycoprotein-IgG (MOG-IgG) positive or negative, it is unclear whether other MOG-antibody–...
- 1 September 2026
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 13 (5) , e200635
Open AccessMOGAD-Like Encephalitic Syndromes Without MOG Antibodies in Children
Background and ObjectivesAlthough acute disseminated encephalomyelity (ADEM) can be myelin oligodendrocyte glycoprotein-IgG (MOG-IgG) positive or negative, it is unclear whether other MOG-antibody–...
- 19 September 2023
- Published by Georg Thieme Verlag KG in Journal of Pediatric Neurology
- Vol. 21 (06) , 445-449
A Rare Occurrence of Demyelinating Lesions of Bilateral Trigeminal Nerves: An Atypical Presentation of Pediatric Multiple Sclerosis
Pontine trigeminal root entry zone is a typical, although uncommon, location for multiple sclerosis (MS) lesions to occur. Here, we present a 17-year-old girl with nausea, vomiting, and vertigo. Neurological examination was consistent with central nystagmus, positive Romberg's test, and left-sided hyperreflexia. Baseline magnetic resonance imaging fulfilled McDonald 2017 criteria for MS and showed T2-hyperintense and T1-hypointense bilateral demyelinating lesions at the intramedullary portion of the trigeminal root of the fifth nerve, with no contrast enhancement or restricted diffusion. Bilateral intrapontine trigeminal involvement is a rare finding in MS, as well as the combined central and peripheral demyelination. Furthermore, very limited information and cases have been described in pediatric patients.
- 19 September 2023
- Published by Georg Thieme Verlag KG in Journal of Pediatric Neurology
- Vol. 21 (06) , 445-449
A Rare Occurrence of Demyelinating Lesions of Bilateral Trigeminal Nerves: An Atypical Presentation of Pediatric Multiple Sclerosis
Pontine trigeminal root entry zone is a typical, although uncommon, location for multiple sclerosis (MS) lesions to occur. Here, we present a 17-year-old girl with nausea, vomiting, and vertigo. Neurological examination was consistent with central nystagmus, positive Romberg's test, and left-sided hyperreflexia. Baseline magnetic resonance imaging fulfilled McDonald 2017 criteria for MS and showed T2-hyperintense and T1-hypointense bilateral demyelinating lesions at the intramedullary portion of the trigeminal root of the fifth nerve, with no contrast enhancement or restricted diffusion. Bilateral intrapontine trigeminal involvement is a rare finding in MS, as well as the combined central and peripheral demyelination. Furthermore, very limited information and cases have been described in pediatric patients.
- Open Access
- 27 March 2023
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1178013
Corrigendum: Steroid treatment response to post SARS-CoV-2 PANS symptoms: Case series
Corrigendum: Steroid treatment response to post SARS-CoV-2 PANS symptoms: Case series
- 27 March 2023
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1178013
Open AccessCorrigendum: Steroid treatment response to post SARS-CoV-2 PANS symptoms: Case series
Corrigendum: Steroid treatment response to post SARS-CoV-2 PANS symptoms: Case series